| Titolo | Fase | Stato | Sede patologia | Strutture coinvolte | Dettaglio |
A PHASE 3 RANDOMIZED, OPEN-LABEL, MULTICENTER STUDY TO COMPARE THE EFFICACY AND SAFETY OF SACITUZUMAB TIRUMOTECAN IN COMBINATION WITH PEMBROLIZUMAB VERSUS PEMBROLIZUMAB ALONE AS FIRST-LINE MAINTENANCE TREATMENT IN PARTICIPANTS WITH MISMATCH REPAIR PROFICIENT ENDOMETRIAL CANCER (TROFUSE-033/GOG-3119/ENGOT-EN29) |
III |
in corso |
CANCRO ENDOMETRIALE |
- SC Oncologia Clinica Sperimentale Uro - Ginecologica |
|
A PHASE 3, MULTICENTER, RANDOMIZED, OPEN LABEL STUDY TO COMPARE THE EFFICACY AND SAFETY OF GOLCADOMIDE IN COMBINATION WITH RITUXIMAB (GOLCA + R) VS INVESTIGATOR’S CHOICE IN PARTICIPANTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA |
III |
in corso |
LINFOMA |
- SC Ematologia Oncologica |
|
IZABRIGHT-BREAST01 - A RANDOMIZED, OPEN-LABEL, INFERENTIALLY SEAMLESS PHASE 2/3 STUDY OF IZALONTAMAB BRENGITECAN (BMS-986507) VERSUS TREATMENT OF PHYSICIAN’S CHOICE IN PATIENTS WITH PREVIOUSLY UNTREATED, LOCALLY ADVANCED, RECURRENT INOPERABLE, OR METASTATIC TRIPLENEGATIVE BREAST CANCER (TNBC) OR ER-LOW, HER2-NEGATIVE BC WHO ARE INELIGIBLE FOR ANTI- PD1/PD-L1 TREATMENT |
II/III |
in corso |
CARCINOMA MAMMARIO |
- SC Oncologia Clinica Sperimentale di Senologia |
|
A MULTICENTRE, OPEN-LABEL, PHASE 3, RANDOMISED CONTROLLED TRIAL OF DUVELISIB VERSUS INVESTIGATOR’S CHOICE OF GEMCITABINE OR BENDAMUSTINE IN PATIENTS WITH RELAPSED/REFRACTORY NODAL T CELL LYMPHOMA WITH T FOLLICULAR HELPER (TFH) PHENOTYPE (TERZO) |
III |
in corso |
linfoma |
- SC Ematologia Oncologica |
|
CIRCULATING EBV-DNA CHANGES IN TAILORING TREATMENT OF LOCALLY ADVANCED NASOPHARYNGEAL CARCINOMA: THE PHASE 2 TRIAL INTERLAYER |
NA |
in corso |
CARCINOMA NASOFARINGEO |
- SC Oncologia Clinica Sperimentale Testa – Collo |
